Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer

PURPOSE: New treatment strategies, particularly the introduction of molecular-targeted agents and appropriate patient selection based on histology and/or genotyping, have progressed markedly in recent years, and the overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patients has im...

Descripción completa

Detalles Bibliográficos
Autores principales: Aboshi, Masayuki, Kaneko, Masayuki, Narukawa, Mamoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article - Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983956/
https://www.ncbi.nlm.nih.gov/pubmed/24562618
http://dx.doi.org/10.1007/s00432-014-1617-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983956/
https://www.ncbi.nlm.nih.gov/pubmed/24562618
http://dx.doi.org/10.1007/s00432-014-1617-3

Ejemplares similares